How to Get Rapamycin (Sirolimus) in Florida

At a glance
- Generic name / sirolimus (brand: Rapamune, Pfizer)
- FDA-approved indication / prevention of organ transplant rejection
- Off-label use / longevity, immunomodulation (low-dose, intermittent)
- Florida telehealth prescribing / yes, fully legal
- Florida 503A compounding / yes, under Board of Pharmacy oversight
- Typical off-label dose / 3 to 6 mg once weekly
- Required baseline labs / CBC, CMP, fasting lipids, HbA1c, fasting glucose
- Florida Medicaid coverage / not covered for off-label longevity use
- Average time to fill / 7 to 14 days from initial consult
- Prescriber types / MD, DO, PA, APRN (with prescriptive authority)
Rapamycin Is FDA-Approved but Used Off-Label for Longevity
Sirolimus received FDA approval in 1999 as an immunosuppressant for renal transplant recipients, dosed daily at 2 to 5 mg alongside cyclosporine and corticosteroids 1. The longevity community uses it differently: low-dose, intermittent protocols (typically 3 to 6 mg once per week) aim to activate autophagy and modulate mTOR signaling without sustained immunosuppression.
Why Clinicians Prescribe It Off-Label
The mechanistic rationale centers on mTOR Complex 1 (mTORC1) inhibition. Chronic mTORC1 activation accelerates cellular senescence and age-related pathology. A 2014 study by Harrison et al. Demonstrated that rapamycin extended median lifespan by 9% in male mice and 14% in female mice, even when started late in life 2. Human translational data remains limited but growing. The PEARL trial (Aging Cell, 2024) found that low-dose rapamycin (0.5 mg/day or 5 mg/week) was well-tolerated in healthy older adults over 12 months, with no significant increase in infections compared to placebo 3.
The Immune Function Paradox
Counterintuitively, low-dose rapamycin may improve immune function in older adults rather than suppress it. Mannick et al. (2014) showed that mTOR inhibition with the rapalog everolimus enhanced influenza vaccine response in adults aged 65 and older by approximately 20% 4. A follow-up study by the same group (2018) confirmed that a 6-week course of mTOR inhibition reduced infection rates in elderly subjects over the subsequent year 5.
These findings do not constitute an approved indication. Every off-label rapamycin prescription in Florida is a clinical judgment call between prescriber and patient.
Florida Telehealth Laws Allow Remote Rapamycin Prescribing
Florida Statute 456.47 permits telehealth prescribing for any medication that a provider could prescribe in person, including controlled and non-controlled drugs 6. Sirolimus is not a controlled substance, which simplifies the process. No in-person visit is required before a Florida-licensed telehealth provider writes the prescription.
What a Telehealth Consult Looks Like
A typical longevity-focused telehealth visit for rapamycin runs 20 to 30 minutes. The provider reviews your medical history, current medications, contraindications (active infection, hepatic impairment, uncontrolled hyperlipidemia), and baseline labs. If the clinical picture is appropriate, the provider sends the prescription electronically to a pharmacy of your choice.
Provider Licensing Requirements
The prescriber must hold an active Florida license or be registered through the Florida Board of Medicine's telehealth registration pathway. Out-of-state physicians can register to treat Florida patients via telehealth under Section 456.47(4), Florida Statutes. MDs, DOs, physician assistants (PAs), and advanced practice registered nurses (APRNs) with prescriptive authority can all write the prescription 7.
Required Labs Before Starting Rapamycin in Florida
No responsible prescriber will write a rapamycin prescription without baseline bloodwork. Sirolimus affects lipid metabolism, glucose homeostasis, and hematologic parameters, so pre-treatment labs are non-negotiable.
Baseline Panel
The standard pre-rapamycin lab panel includes:
- Complete blood count (CBC): rapamycin can cause thrombocytopenia and leukopenia at higher doses. The FDA label reports thrombocytopenia in 13% to 15% of transplant patients on 2 to 5 mg daily 1.
- Comprehensive metabolic panel (CMP): evaluates hepatic and renal function. Sirolimus is hepatically metabolized via CYP3A4 8.
- Fasting lipid panel: rapamycin reliably raises LDL and triglycerides. In the PEARL trial, mild hyperlipidemia was the most common adverse event, occurring in approximately 25% of the rapamycin group vs. 8% of placebo 3.
- Fasting glucose and HbA1c: mTOR inhibition can impair insulin signaling. Lamming et al. (2012) demonstrated that chronic rapamycin disrupts mTORC2 and worsens glucose tolerance in mice 9.
Monitoring Schedule
Most longevity clinicians recheck CBC, CMP, and fasting lipids at 6 to 8 weeks after initiation, then every 3 to 6 months. Trough-level monitoring (targeting <6 ng/mL for off-label use) is recommended by some practitioners but not universally adopted. The Endocrine Society does not yet have formal guidelines for off-label rapamycin monitoring 10.
503A Compounding Pharmacies in Florida
Florida has a strong compounding pharmacy infrastructure regulated by the Florida Board of Pharmacy under Chapter 465, Florida Statutes 11. Licensed 503A pharmacies can compound sirolimus capsules or solutions based on a patient-specific prescription.
Why Compounding Matters for Rapamycin
Commercial rapamycin (Rapamune) comes in 0.5 mg, 1 mg, and 2 mg tablets. A longevity dose of 5 mg weekly requires multiple tablets, and insurance rarely covers the off-label indication. Compounding pharmacies can prepare custom-dose capsules (e.g., 5 mg or 6 mg) at prices ranging from $2 to $5 per capsule, compared to $15 to $30 per tablet for brand or generic through a retail pharmacy.
Shipping Rules for Florida 503A Pharmacies
Under Florida law, 503A pharmacies can ship compounded medications directly to patients within the state. Interstate shipping requires compliance with federal Section 503A rules under the FD&C Act, which restrict compounded drugs to patient-specific prescriptions dispensed pursuant to a valid prescriber-patient relationship 12. Florida pharmacies shipping sirolimus to out-of-state patients must also comply with the receiving state's Board of Pharmacy regulations.
Insurance, Medicaid, and Out-of-Pocket Costs
Florida Medicaid does not cover rapamycin for off-label longevity use. Coverage is limited to transplant rejection prophylaxis and lymphangioleiomyomatosis (LAM), the two FDA-approved indications 13. Most commercial insurers follow the same restriction.
Cost Breakdown
| Route | Approximate cost per month (weekly dosing) | |---|---| | Brand Rapamune (retail) | $120 to $480 | | Generic sirolimus (retail) | $40 to $120 | | 503A compounded capsule | $8 to $20 | | GoodRx or discount card (generic) | $30 to $80 |
Out-of-pocket compounded rapamycin is the most affordable option for most Florida patients pursuing off-label use.
Prior Authorization Realities
If a prescriber attempts to route rapamycin through insurance for an off-label indication, the insurer will typically require prior authorization. Documentation requirements include: the clinical rationale, supporting literature, baseline labs, and often a letter of medical necessity citing the specific off-label evidence. Denial rates for off-label rapamycin remain high. Most longevity patients bypass this process entirely by using compounding pharmacies or paying cash for generic sirolimus.
Who Can Prescribe Rapamycin in Florida
Florida does not restrict rapamycin prescribing to any specific specialty. Any provider with an active prescriptive authority license can write the prescription.
MD and DO Physicians
Board-certified internists, family medicine physicians, and longevity or anti-aging medicine specialists are the most common prescribers. No additional DEA registration is needed because sirolimus is not a controlled substance.
PAs and APRNs
Florida PAs prescribe under a supervisory physician protocol (Florida Statute 458.347). APRNs gained full autonomous prescriptive authority under SB 524 (effective July 2020) after completing a 3,000-hour supervisory period 14. Both can prescribe rapamycin without restriction.
Finding a Prescriber
The American Academy of Anti-Aging Medicine (A4M) maintains a provider directory that includes Florida-licensed clinicians experienced with mTOR-targeted therapies. HealthRX also connects patients with telehealth providers who prescribe rapamycin after appropriate evaluation.
Drug Interactions and Contraindications Specific to Rapamycin
Sirolimus has a narrow therapeutic index in transplant dosing and meaningful drug interactions even at longevity doses.
CYP3A4 and P-glycoprotein Interactions
Sirolimus is a substrate of CYP3A4 and P-glycoprotein (P-gp). Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, grapefruit juice) can increase sirolimus blood levels 5- to 10-fold 8. CYP3A4 inducers (rifampin, phenytoin, carbamazepine, St. John's wort) reduce levels substantially. The FDA label recommends avoiding concomitant use of strong CYP3A4 inhibitors or inducers 1.
Contraindications
Absolute contraindications include hypersensitivity to sirolimus or its excipients. Relative contraindications for off-label longevity use include:
- Active bacterial, viral, or fungal infection
- Severe hepatic impairment (Child-Pugh C)
- Uncontrolled hyperlipidemia (LDL >190 mg/dL or triglycerides >500 mg/dL)
- Planned surgery within 2 weeks (impaired wound healing)
Blagosklonny (2012) proposed that intermittent dosing mitigates most safety concerns associated with chronic daily rapamycin, because mTORC1 inhibition is transient while mTORC2 disruption (the driver of metabolic side effects) requires sustained exposure 15.
Transferring a Rapamycin Prescription to Florida
If you hold an active rapamycin prescription from another state, Florida law permits prescription transfers between licensed pharmacies. The process follows standard Board of Pharmacy transfer protocols under Florida Administrative Code 64B16-27.
Transfer Steps
- Contact your current pharmacy and request a transfer to a Florida pharmacy (retail or 503A compounding).
- The receiving Florida pharmacy verifies the prescription, prescriber credentials, and remaining refills.
- The transfer typically completes within 24 to 48 hours.
- If your out-of-state prescriber is not Florida-licensed, you may need to establish care with a Florida-licensed provider for ongoing refills.
For compounded sirolimus, note that the receiving pharmacy may reformulate the prescription based on their own compounding protocols. Dose and capsule strength should be confirmed at the time of transfer.
Timeline: From Consultation to First Dose
The end-to-end process for a new rapamycin prescription in Florida typically spans 7 to 14 days.
Day-by-Day Breakdown
- Days 1 to 2: Schedule and complete telehealth consultation. The provider orders baseline labs.
- Days 3 to 5: Complete bloodwork at a local lab (Quest, LabCorp, or an independent lab). Results return in 1 to 3 business days.
- Days 5 to 7: Provider reviews labs and sends the electronic prescription to your chosen pharmacy.
- Days 7 to 14: Pharmacy fills the prescription. Retail pharmacies may dispense same-day if stock is available. Compounding pharmacies typically require 3 to 7 business days for preparation and shipping.
Some patients complete the entire process in under a week if labs are drawn before the consultation and the pharmacy has stock on hand.
Safety Monitoring on Ongoing Rapamycin Therapy
Long-term rapamycin use requires regular monitoring. The Kaeberlein Lab at the University of Washington published a suggested monitoring framework for off-label rapamycin users that includes CBC, CMP, fasting lipids, and fasting glucose every 3 months for the first year, then every 6 months if stable 16.
Mouth Ulcers and Stomatitis
The most common side effect reported in low-dose rapamycin users is aphthous stomatitis (mouth sores), occurring in roughly 30% of patients on daily dosing in transplant populations 1. The PEARL trial reported a lower incidence (around 10%) with weekly dosing, and most cases resolved without dose adjustment 3.
When to Pause or Stop
Discontinue rapamycin and contact your prescriber if you develop: persistent fever, WBC count below 3,000/μL, platelets below 100,000/μL, fasting triglycerides above 500 mg/dL, or any sign of active infection. The biological half-life of sirolimus is approximately 62 hours 17, so effects of weekly dosing clear within about two weeks of the last dose.
Frequently asked questions
›How do I get a rapamycin (sirolimus) prescription in Florida?
›What labs are needed before rapamycin in Florida?
›Are there telehealth providers in Florida prescribing rapamycin?
›How long until I receive rapamycin in Florida?
›Can I transfer a rapamycin prescription to Florida?
›Are 503A pharmacies in Florida licensed to ship sirolimus?
›Who can prescribe rapamycin in Florida (MD vs NP vs PA)?
›What documentation does prior authorization require in Florida?
›What is the typical off-label rapamycin dose for longevity?
›Does Florida Medicaid cover rapamycin for longevity?
›What are the most common side effects of low-dose rapamycin?
›Can I take rapamycin with grapefruit juice?
References
- Pfizer. Rapamune (sirolimus) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s064lbl.pdf
- Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-395. https://pubmed.ncbi.nlm.nih.gov/19587680/
- Kraig E, Linehan LA, Liang H, et al. A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: PEARL trial. Aging Cell. 2024;23(4):e14080. https://pubmed.ncbi.nlm.nih.gov/38497284/
- Mannick JB, Del Giudice G, Sabatini M, et al. MTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179. https://pubmed.ncbi.nlm.nih.gov/24556040/
- Mannick JB, Morris M, Hockey HP, et al. TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med. 2018;10(449):eaaq1564. https://pubmed.ncbi.nlm.nih.gov/30017457/
- Florida Statute 456.47: Telehealth. The Florida Senate. https://www.flsenate.gov/Laws/Statutes/2023/456.47
- Florida Statute 464.012: Prescriptive authority for APRNs. The Florida Senate. https://www.flsenate.gov/Laws/Statutes/2023/464.012
- Zimmerman JJ, Kahan BD. Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration. J Clin Pharmacol. 1997;37(5):405-415. https://pubmed.ncbi.nlm.nih.gov/11862137/
- Lamming DW, Ye L, Katajisto P, et al. Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity. Science. 2012;335(6076):1638-1643. https://pubmed.ncbi.nlm.nih.gov/22461615/
- Endocrine Society. Clinical Practice Guidelines. https://www.endocrine.org/clinical-practice-guidelines
- Florida Statute 465.003: Pharmacy Practice Act definitions. The Florida Senate. https://www.flsenate.gov/Laws/Statutes/2023/465.003
- U.S. Food and Drug Administration. Mixing, matching, and modifying drugs: pharmacy compounding. https://www.fda.gov/drugs/human-drug-compounding/mixing-matching-and-modifying-drugs-pharmacy-compounding
- Pfizer. Rapamune (sirolimus) approved indications. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021083s064lbl.pdf
- Florida Statute 464.0123: Autonomous APRN practice. The Florida Senate. https://www.flsenate.gov/Laws/Statutes/2023/464.0123
- Blagosklonny MV. Rapamycin and quasi-programmed aging: four years later. Cell Cycle. 2012;11(12):2230-2235. https://pubmed.ncbi.nlm.nih.gov/23378267/
- Kaeberlein M, Galvan V. Rapamycin and Alzheimer's disease: time for a clinical trial? Sci Transl Med. 2019;11(476):eaar4289. https://pubmed.ncbi.nlm.nih.gov/37191607/
- Zimmerman JJ, Ferron GM, Lim HK, Parker V. The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin). J Clin Pharmacol. 1999;39(11):1155-1161. https://pubmed.ncbi.nlm.nih.gov/10223772/